Author

Akihiko Saitoh

Niigata University - Cited by 3,146 - Pediatric Infectious Diseases

Biography

Dr. Akihiko Saitoh, MD is a board certified Pediatric infectious disease specialist in La Jolla, California. He is currently licensed to practice medicine in California. He has completed his education and training from University of California San Diego and University of Southern California-LAC+USA medical centre. His major research is focusses on HIV. He is a member of American board of Pediatric infectious diseases and also holds CA state medical license. He has more than 30 research publications in high-indexed journals. 
Title
Cited by
Year
Changes in childhood vaccination during the coronavirus disease 2019 pandemic in Japan
Y Aizawa, T Katsuta, H Sakiyama, K Tanaka-Taya, H Moriuchi, A SaitohVaccine 39 (29), 4006-4012, 2021202
18
2021
High rates of vaccine hesitancy among pregnant women during the coronavirus disease 2019 (COVID-19) pandemic in Japan
A Saitoh, M Takaku, A SaitohHuman vaccines & immunotherapeutics 18 (5), 2064686, 2022202
12
2022
Outbreak of Enterovirus D68 among Children in Japan—Worldwide Circulation of Enterovirus D68 Clade B3 in 2018
T Ikuse, Y Aizawa, T Yamanaka, R Habuka, K Watanabe, T Otsuka, ...The Pediatric infectious disease journal 40 (1), 6-10, 2020202
11
2020
The clinical characteristics of pediatric coronavirus disease 2019 in 2020 in Japan
T Katsuta, N Shimizu, K Okada, K Tanaka‐Taya, T Nakano, H Kamiya, ...Pediatrics International 64 (1), e14912, 2022202
11
2022
Degeneration of dopaminergic neurons and impaired intracellular trafficking in Atp13a2 deficient zebrafish
H Nyuzuki, S Ito, K Nagasaki, Y Nitta, N Matsui, A Saitoh, H MatsuiIBRO reports , 1-8, 2020202
9
2020
Coronavirus disease 2019 cluster originating in a Primary School Teachers’ Room in Japan
Y Aizawa, Y Shobugawa, N Tomiyama, H Nakayama, M Takahashi, ...The Pediatric infectious disease journal 40 (11), e418, 2021202
7
2021
Development of novel PCR assays for improved detection of enterovirus D68
T Ikuse, Y Aizawa, H Takihara, S Okuda, K Watanabe, A SaitohJournal of clinical microbiology 9 (11), 10.1128/jcm. 0111-21, 2021202
5
2021
Changes and remaining challenges for the Japanese immunization program: Closing the vaccine gap
A Saitoh, N OkabeVaccine 39 (22), 3018-3024, 2021202
5
2021
Comparison of immunization systems in Japan and the United States–What can be learned?
T Katsuta, CA Moser, KA Feemster, A Saitoh, PA OffitVaccine 38 (6), 701-708, 2020202
4
2020
Effect of a vaccine information statement (VIS) on immunization status and parental knowledge, attitudes, and beliefs regarding infant immunization in Japan
A Saitoh, A Saitoh, T Katsuta, M Mine, H Kamiya, I Miyairi, N Ishiwada, ...Vaccine 38 (50), 809-805, 2020202
4
2020
Soluble LR11 as a novel biomarker in acute Kawasaki disease
K Watanabe, H Suzuki, M Jiang, S Tsukano, S Kataoka, S Ito, T Sakai, ...Circulation Journal 86 (6), 977-98, 2022202
3
2022
Changes in exanthema subitum incidence and patient age distribution during the COVID-19 pandemic in Japan
J Tachikawa, Y Aizawa, T Ikuse, M Kon, A SaitohThe Pediatric Infectious Disease Journal 41 (), e90, 2022202
3
2022
Performance of Nanopore and Illumina metagenomic sequencing for pathogen detection and transcriptome analysis in infantile central nervous system infections
K Horiba, Y Torii, Y Aizawa, M Yamaguchi, K Haruta, T Okumura, T Suzuki, ...Open Forum Infectious Diseases 9 (10), ofac504, 2022202
3
2022
Skin thickness in neonates: Implications for intradermal vaccination
A Saitoh, J Nirei, T Tanaka, H Haniu, T Sakai, S Okubo, H HiranoVaccine 8 (5), 5659-5664, 2020202
3
2020
Pilot study of evaluating attitudes toward childhood immunization among healthcare workers in Japan
A Saitoh, Y Shobugawa, I Sato, Y Yonekura, A Kawabata, A Saitoh, ...Vaccines 10 (7), 1055, 0
2
2022
Clinically mild encephalitis/encephalopathy with a reversible splenial lesion associated with rhinovirus
N Soma, Y Aizawa, M Matsunaga, A SaitohThe Pediatric Infectious Disease Journal 40 (3), e1-e15, 010
2
2021
Effectiveness of 4-1BB-costimulated HER2-targeted chimeric antigen receptor T cell therapy for synovial sarcoma
Effectiveness of 4-1BB-costimulated HER-targeted chimeric antigen receptor T cell therapy for synovial sarcomaY Murayama, H Kawashima, N Kubo, C Shin, Y Kasahara, M Imamura, ...Translational Oncology 14 (1), 1017, 010
2
2021
Genotyping and macrolide-resistant mutation of Bordetella pertussis in East and South-East Asia
K Koide, SM Yao, CS Chiang, PTB Thuy, TM Dien, O Vichit, Y Vutthikol, ...Journal of Global Antimicrobial Resistance 31, 63-69, 0
2
2022
Comparison of Clinical Characteristics of Children Infected with Coronavirus Disease 2019 between Omicron Variant BA. 5 and BA. 1/BA. 2 in Japan
Comparison of Clinical Characteristics of Children Infected with Coronavirus Disease 209 between Omicron Variant BA. 5 and BA. /BA. 2 in JapanT Ikuse, Y Aizawa, T Yamanaka, S Hasegawa, T Hayashi, M Kon, ...The Pediatric Infectious Disease Journal 42 (6), 503-509, 2023202
1
2023
Molecular Evolution and Epidemiology of Parechovirus-A3 in Japan, 1997–2019
Molecular Evolution and Epidemiology of Parechovirus-A3 in Japan, 997–209Y Aizawa, T Kasamatsu, K Nagasawa, K Watanabe, A SaitohThe Journal of Infectious Diseases 227 (2), 288-294, 2023202
1
2023

Referred From: https://scholar.google.com/citations?user=2NfPqsAAAAAJ&hl=ja

Cited by
Citations 3146
h-index 29
i10-index 82
Recommended Journals
Open Access Journals